Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (1137)	12/19/1997 8:01:00 PM
From: bdusa1	Read Replies (1) \| Respond to of 7041

In this instance Mr. Wexler I think you are mistaken and of course in due time we will know. Asensio finally made a mistake and you fell for it. IMHO

To: Bill Wexler who wrote (1137)	12/19/1997 9:56:00 PM
From: Claud B	Read Replies (1) \| Respond to of 7041

Could you please be more specific about FACT # 7? Maybe we're onto something really big. ClaudB

To: Bill Wexler who wrote (1137)	12/20/1997 2:05:00 AM
From: Bruce Rosen	Read Replies (2) \| Respond to of 7041

Bill (the Shill?) thoughtfully observes: <<Results speak for themselves. So far I have seen the following: 1) FACT - Zonagen has not produced a unique drug.>> They have a unique formulation of phentolamine called Vasomax. They also are working on a drug combining Vasomax and a phosphodiesterase inhibitor, which is the same class of drug as Viagra. They are working on a version of Vasomax for females and have other potential drugs relating to reproductive health care in the pipeline. <<2) FACT - Zonagen has not filed an NDA.>> Which proves nothing. Every new development stage company has been in a position where they haven't filed yet. If they had, they wouldn't be development stage. Get the idea? They have found a marketing partner called Schering-Plough who is involved in putting that NDA together right now. <<3) FACT - Zonagen results from its clinical trials have been obfuscated and show no conclusive evidence of efficacy.>> The results, as tabulated by PPD Pharmaco, have been reported and were far better than is necessary for FDA approval. What are you referring to by the word "obfuscated?" 4) FACT - Zonagen's patent is worthless for the oral administration of phentolamine mesylate. Apparently Schering disagrees with you on Zonagen's patent position. Who to believe??? <<5) FACT - Zonagen has now lost over $50 million.>> Again, not at all unusual for a development stage company. What is unusual is they can cover that with just the remainder of their upfront payment of $47.5 million. Royalties will be gravy that flows directly to the bottom line. <<6) FACT - Zonagen's stock price has dropped 50% in the course of a few weeks on heavy volume.>> Even after that, it has doubled in the last year. There is every reason to expect a big turnaround. Many companies in the tech and biotech area have this kind of volatility. <<7) FACT - Zonagen has hired paid shills and touts to write misleading research reports.>> Like everything else you have posted, you offer not one iota of proof of this. <<8) FACT - Zonagen has a long history of selling stock but not delivering revenues.>> Do you mean revenues or earnings. Are you the kind of CPA who doesn't understand the distinction? They have revenues. They have successfully financed their research and development by selling equity and are now among the most cash rich of development stage biotechs, with excellent prospects of a tremendous return to the investors. All this with a share base, fully diluted of around 13 1/2 million shares. <<9) FACT - Zonagen announced a dubious stock buyback for $10,000,000 even though they are a cash-burning development stage company with no revenues. >> Many companies announce stock buybacks. It happens all the time, often with excellent results. They have more than enough cash to finance operations and research for years. Your "facts," Bill, are mere repetitions of nonsense that has appeared for months on these message boards. They couldn't be defended then and you have shown no ability to address anything in a detailed way now. You provide attacks and challenges that are always answered and are never able to respond to the same. I suspect anyone who came to these message boards with an open mind would see that immediately.